ESC Working Groups bring experts in their field to provide education, share expertise and facilitate exchange for best practice and ongoing medical development. Discover the ESC Working Group that gets to the heart of your sub-specialty in the cardiovascular field and join today.
Discover upcoming events in your field of expertise. Mark your calendar and get involved.
Take advantage of educational resources to develop your knowledge and skills.
Join the ESC Working Group that best represents your area of expertise and being part of a vibrant community.
Retrieve all sessions and activities of your dedicated Working Groups at ESC Congress.
High quality plenary and keynote lectures by experts in cardiovascular pharmacotherapy as well as several activities dedicated to the CPPTs and the members of the ESC young communities.
Every year the Working Group on Cardiovascular Pharmacotherapy organises EuroCVP Meeting to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologists with an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.
All cardiologists are concerned by pharmacology and drugs therapy, thus, they should all participate and contribute to EuroCVP.
During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.
The ESC Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
Gathering more than 20 experts from the Heart Failure Association and the ESC Working Group on Myocardial Function with the aim of developing a HFA Position Statement on the Pathophysiology of Takotsubo syndrome.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, France
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved